SEC Actions- Salix, Walgreens, & LendingClub Asset Management
Salix and Its Former CFO Charged with Repeatedly Misleading Analysts and Investors On September 28, 2018, the Securities and Exchange Commission announced that it charged Salix Pharmaceuticals Ltd. (“Salix”) and its former CFO with repeatedly misleading analysts and investors about... Read More →